374 related articles for article (PubMed ID: 33264681)
21. Cardiac amyloidosis: pathogenesis, clinical context, diagnosis and management options.
Alkhawam H; Patel D; Nguyen J; Easaw SM; Al-Sadawi M; Syed U; Zaiem F; Homsi M; Vittorio TJ
Acta Cardiol; 2017 Aug; 72(4):380-389. PubMed ID: 28705053
[TBL] [Abstract][Full Text] [Related]
22. Renal amyloidosis complicated by light chain deposition nephropathy: a case report.
Yu X; Lan P; Feng J; Feng X; Xie L
Int J Clin Exp Pathol; 2019; 12(6):2279-2283. PubMed ID: 31934052
[TBL] [Abstract][Full Text] [Related]
23. AL amyloidosis with a localized B cell neoplasia.
Stuhlmann-Laeisz C; Schönland SO; Hegenbart U; Oschlies I; Baumgart JV; Krüger S; Röcken C
Virchows Arch; 2019 Mar; 474(3):353-363. PubMed ID: 30680453
[TBL] [Abstract][Full Text] [Related]
24. Coexistence of variant-type transthyretin and immunoglobulin light-chain amyloidosis: a case report.
Eda Y; Ishii S; Onagi S; Katoh N; Ako J
Eur Heart J Case Rep; 2024 Jun; 8(6):ytae264. PubMed ID: 38872953
[TBL] [Abstract][Full Text] [Related]
25. Restrictive cardiomyopathy with kappa light chain deposits in myocardium as a complication of multiple myeloma. Histochemical and electron microscopic observations.
McAllister HA; Seger J; Bossart M; Ferrans VJ
Arch Pathol Lab Med; 1988 Nov; 112(11):1151-4. PubMed ID: 3140760
[TBL] [Abstract][Full Text] [Related]
26. [Cardiac amyloidosis: pathological classification and clinical analysis of 48 cases].
Yu TP; Hou J; Yang TJ; Lei S; Yang M; Su YY; Chen YC; Wu Y; Chen XQ
Zhonghua Bing Li Xue Za Zhi; 2023 Jul; 52(7):671-677. PubMed ID: 37408396
[No Abstract] [Full Text] [Related]
27. Systemic kappa light-chain deposition. An ultrastructural and immunohistochemical study.
Linder J; Croker BP; Vollmer RT; Shelburne J
Am J Surg Pathol; 1983 Jan; 7(1):85-93. PubMed ID: 6402947
[TBL] [Abstract][Full Text] [Related]
28. Immunoglobulin light chain amyloidosis: 2018 Update on diagnosis, prognosis, and treatment.
Gertz MA
Am J Hematol; 2018 Sep; 93(9):1169-1180. PubMed ID: 30040145
[TBL] [Abstract][Full Text] [Related]
29. Diagnosis and management of systemic light chain AL amyloidosis.
Bhutani D; Lentzsch S
Pharmacol Ther; 2020 Oct; 214():107612. PubMed ID: 32562825
[TBL] [Abstract][Full Text] [Related]
30. Additional diagnostic value of electron microscopic examination in endomyocardial biopsy in patients with suspected non-ischemic cardiomyopathy.
Yamamoto M; Sato K; Murakoshi N; Yamada Y; Nakagawa D; Nakatsukasa T; Ishizu T; Ieda M
J Cardiol; 2023 Feb; 81(2):236-243. PubMed ID: 36182004
[TBL] [Abstract][Full Text] [Related]
31. Nodular pulmonary immunoglobulin light chain deposits with coexistent amyloid and nonamyloid features in an HIV-infected patient.
Stokes MB; Jagirdar J; Burchstin O; Kornacki S; Kumar A; Gallo G
Mod Pathol; 1997 Oct; 10(10):1059-65. PubMed ID: 9346188
[TBL] [Abstract][Full Text] [Related]
32. The utility of repeat kidney biopsy in systemic immunoglobulin light chain amyloidosis.
Angel-Korman A; Jaberi A; Sanchorawala V; Havasi A
Amyloid; 2020 Mar; 27(1):17-24. PubMed ID: 31595786
[No Abstract] [Full Text] [Related]
33. Cardiac amyloidosis as a rare cause of heart failure: A case report.
Gao M; Liu Q; Chen L
Medicine (Baltimore); 2019 Apr; 98(14):e15036. PubMed ID: 30946343
[TBL] [Abstract][Full Text] [Related]
34. [Renal disorders associated with monoclonal gammopathies: diagnostic and therapeutic progress].
Bridoux F; Delbes S; Sirac C; Pourreau F; Puyade M; Desport E; Jaccard A; Fermand JP; Touchard G
Presse Med; 2012 Mar; 41(3 Pt 1):276-89. PubMed ID: 22244725
[TBL] [Abstract][Full Text] [Related]
35. Cardiac amyloidosis: five cases diagnosed by endomyocardial biopsy.
Silvestri F; Tanganelli P; Salvi A; Bussani R; Petrelli L; Pinamonti B; Camerini F
Appl Pathol; 1985; 3(1-2):69-77. PubMed ID: 3842071
[TBL] [Abstract][Full Text] [Related]
36. Advanced isolated light chain amyloid cardiomyopathy with negative immunofixation and normal free light chain ratio.
Zach D; Ablasser K; Kolesnik E; Hoeller V; Fruhwald F; Prüller F; Reiter C; Beham-Schmid C; Lipp R; Rainer PP; Zirlik A; Wölfler A; Verheyen N
ESC Heart Fail; 2021 Aug; 8(4):3397-3402. PubMed ID: 33960730
[TBL] [Abstract][Full Text] [Related]
37. Cryo-EM structure of a light chain-derived amyloid fibril from a patient with systemic AL amyloidosis.
Radamaker L; Lin YH; Annamalai K; Huhn S; Hegenbart U; Schönland SO; Fritz G; Schmidt M; Fändrich M
Nat Commun; 2019 Mar; 10(1):1103. PubMed ID: 30894526
[TBL] [Abstract][Full Text] [Related]
38. IgM monoclonal gammopathy with heavy-and-light-chain amyloidosis resembling fibrillary glomerulonephritis determined by tandem mass spectrometry: a case report.
Adachi M; Kitamura M; Muta K; Maekawa A; Uramatsu T; Tadokoro M; Funakoshi S; Hisano S; Kuwahara N; Shimizu A; Mukae H; Nishino T
BMC Nephrol; 2020 May; 21(1):195. PubMed ID: 32448180
[TBL] [Abstract][Full Text] [Related]
39. Outcomes of autologous stem cell transplant for cardiac AL-amyloidosis and cardiac light chain deposition disease.
Abdallah AA; Alapat D; Kaur V; Atrash S
J Oncol Pharm Pract; 2020 Jul; 26(5):1128-1133. PubMed ID: 31795821
[TBL] [Abstract][Full Text] [Related]
40. Late gadolinium enhancement in cardiac amyloidosis: attributable both to interstitial amyloid deposition and subendocardial fibrosis caused by ischemia.
Hashimura H; Ishibashi-Ueda H; Yonemoto Y; Ohta-Ogo K; Matsuyama TA; Ikeda Y; Morita Y; Yamada N; Yasui H; Naito H
Heart Vessels; 2016 Jun; 31(6):990-5. PubMed ID: 25794983
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]